Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers
Stock Information for Monopar Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.